newsfilter
← Latest News
GlobeNewswire·

argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026

February 19, 2026Amsterdam, the Netherlands – argenx ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that